Hunan Zhongwei Pharmaceutical Co. Ltd.

To evaluate the safety and efficacy of compound omeprazole dry suspension in the treatment of active duodenal ulcer

The pharmacokinetics and bioequivalence test of compound omeprazole dry suspension in healthy subjects was conducted on the compound omeprazole dry suspension developed by Hunan Zhongwei Pharmaceutical Co., Ltd. The corresponding pharmacokinetic parameters were estimated by studying the time course of blood drug concentration after single dose and continuous administration of compound omeprazole dry suspension in healthy subjects, aiming to provide a basis for clinical medication and a reference for the registration and approval of the drug.